Cells rely on RAD52 also when DNA damage overloads the capacity of BRCA1 and 53BP1 (55) which could explain why the RAD52 gene is amplified in human cancers, and why its inactivation curtails cancer development (16,70,71). This evidence concerns the gene TP53BP1 and cancer.